Delcath Systems Inc. Common Stock (DCTH)
Stock · NASDAQ · Health Care
$14.05as of 10/16/2026
Price chart
Active signals
DCTH Signal Track Record
How signals performed across all stocks →What DCTH's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 43 | +3.6% | 56% | August 6, 2026 |
| Bollinger Band Breakout | 29 | +1.4% | 55% | August 6, 2026 |
| Bollinger Band BreakdownActive now | 20 | +1.2% | 55% | September 25, 2026 |
| 200-Day Moving Average TouchActive now | 7 | -6.7% | 43% | April 29, 2026 |
| Any 20-session window (baseline) | +2.6% | 56% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About DCTH
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 156
- Website
- delcath.com/
Fundamentals
- 1-day range
- $14.17$14.83
- Market cap
- $534.05M
- P/E (trailing)
- 962.21
- P/E (forward)
- 315.33
- EPS (trailing)
- $0.01
- Dividend yield
- —
- Beta
- 0.58
- Avg. volume
- 470.9K
- Dividend pay date
- December 24, 2019
Forecasts
5 analyst ratings
Delcath Systems Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- DCTHDelcath Systems Inc. Common Stock$14.08▼ 4.93%Market cap $534.05MP/E 962.21$8.12$17.42
- KIDSOrthoPediatrics Corp. Common Stock$21.95▼ 2.75%Market cap $549.03MP/E —$14.42$26.74
- NPCENeuropace Inc. Common Stock$12.24▼ 4.23%Market cap $473.90MP/E —$9.22$19.6
- CERSCerus Corporation Common Stock$2.18▼ 3.54%Market cap $467.54MP/E —$1.38$3.47
- SIShoulder Innovations Inc. Common Stock$18.09▼ 1.52%Market cap $465.16MP/E —$10.92$24.6
- MDXGMiMedx Group Inc Common Stock$4.43▼ 5.34%Market cap $609.28MP/E 109.34$3.03$7.97
- ANGOAngioDynamics Inc. Common Stock$11.24▼ 2.94%Market cap $624.53MP/E —$9.39$16.29
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| DCTH Delcath Systems Inc. Common Stock | $534.05M | 962.21 | $14.08 | ▼ 4.93% | $8.12$17.42 |
| KIDS OrthoPediatrics Corp. Common Stock | $549.03M | — | $21.95 | ▼ 2.75% | $14.42$26.74 |
| NPCE Neuropace Inc. Common Stock | $473.90M | — | $12.24 | ▼ 4.23% | $9.22$19.6 |
| CERS Cerus Corporation Common Stock | $467.54M | — | $2.18 | ▼ 3.54% | $1.38$3.47 |
| SI Shoulder Innovations Inc. Common Stock | $465.16M | — | $18.09 | ▼ 1.52% | $10.92$24.6 |
| MDXG MiMedx Group Inc Common Stock | $609.28M | 109.34 | $4.43 | ▼ 5.34% | $3.03$7.97 |
| ANGO AngioDynamics Inc. Common Stock | $624.53M | — | $11.24 | ▼ 2.94% | $9.39$16.29 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Delcath Systems Q2 2026 Earnings Call Transcriptbenzinga · 10/6/2026
- Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?Yahoo · 10/1/2026
- 3 Emerging Biotech Stocks With Significant Upside PotentialYahoo · 9/30/2026
- Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?Yahoo · 9/29/2026
- Veracyte (VCYT) Surges 10.8%: Is This an Indication of Further Gains?Yahoo · 9/25/2026
- Are Medical Stocks Lagging Delcath Systems (DCTH) This Year?Yahoo · 9/15/2026
- Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo · 9/11/2026
Insider Activity
Insider Actions →- Gil Aharon · May 13, 2026 · Grant22.5K
- John Richard Sylvester · May 13, 2026 · Grant22.5K
- Martell Bridget A · May 13, 2026 · Grant22.5K
- Steven A. J. Salamon · May 13, 2026 · Grant22.5K
- CZEREPAK ELIZABETH · May 13, 2026 · Grant22.5K
Institutional Ownership
March 31, 2026
- Total shares held
- 16.39M
- Total value held
- $150.26M
- Institutional holders
- 117
- Unknown3.30M
- Unknown1.78M
- Unknown1.33M
- Unknown979.7K
- Unknown692.0K
- Unknown664.4K
- Unknown591.5K
- Unknown588.1K
- Unknown499.8K
- Unknown431.3K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Veracyte stock moves; DCTH shows no related news
Recent news coverage focuses on Veracyte (VCYT) rather than Delcath Systems (DCTH). There are no specific reports or announcements regarding DCTH in the provided data. The stock currently trades with a high trailing P/E ratio, while analyst targets remain above the current price level.
Veracyte stock moves; DCTH shows no related news. Recent news coverage focuses on Veracyte (VCYT) rather than Delcath Systems (DCTH). There are no specific reports or announcements regarding DCTH in the provided data. The stock currently trades with a high trailing P/E ratio, while analyst targets remain above the current price level.